Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Given Consensus Recommendation of “Hold” by Analysts

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) has received an average recommendation of “Hold” from the twelve ratings firms that are presently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, six have issued a hold recommendation and five have issued a buy recommendation on the company. The average 1-year price target among brokerages that have issued a report on the stock in the last year is $21.4545.

SBRA has been the topic of a number of recent research reports. Wall Street Zen raised Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research note on Sunday, June 28th. Citigroup lowered Sabra Healthcare REIT from a “buy” rating to a “neutral” rating and lowered their target price for the company from $24.00 to $19.00 in a research note on Monday, June 22nd. UBS Group dropped their target price on Sabra Healthcare REIT from $22.00 to $21.00 and set a “neutral” rating for the company in a report on Wednesday, July 8th. Truist Financial upgraded Sabra Healthcare REIT from a “hold” rating to a “buy” rating and set a $22.00 price target on the stock in a research report on Wednesday, July 8th. Finally, Scotiabank decreased their price target on Sabra Healthcare REIT from $22.00 to $19.00 and set a “sector perform” rating on the stock in a research note on Thursday, June 18th.

Sabra Healthcare REIT Price Performance

Shares of Sabra Healthcare REIT stock opened at $20.16 on Friday. The company has a debt-to-equity ratio of 0.96, a quick ratio of 4.72 and a current ratio of 4.72. Sabra Healthcare REIT has a 52-week low of $17.17 and a 52-week high of $21.28. The company has a fifty day moving average of $19.61 and a 200-day moving average of $19.74. The stock has a market capitalization of $5.08 billion, a price-to-earnings ratio of 32.00, a price-to-earnings-growth ratio of 1.45 and a beta of 0.65.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 EPS for the quarter, hitting analysts’ consensus estimates of $0.16. The company had revenue of $211.74 million for the quarter, compared to analysts’ expectations of $209.20 million. Sabra Healthcare REIT had a net margin of 19.22% and a return on equity of 5.60%. The firm’s revenue was up 20.9% compared to the same quarter last year. During the same quarter last year, the company earned $0.37 EPS. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Equities research analysts expect that Sabra Healthcare REIT will post 1.5 EPS for the current year.

Sabra Healthcare REIT Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, May 29th. Stockholders of record on Friday, May 15th were issued a $0.30 dividend. The ex-dividend date was Friday, May 15th. This represents a $1.20 annualized dividend and a dividend yield of 6.0%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is currently 190.48%.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the company. Rothschild Investment LLC boosted its position in Sabra Healthcare REIT by 164.6% during the 4th quarter. Rothschild Investment LLC now owns 1,429 shares of the real estate investment trust’s stock valued at $27,000 after buying an additional 889 shares during the period. Smartleaf Asset Management LLC increased its position in shares of Sabra Healthcare REIT by 97.7% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the real estate investment trust’s stock valued at $27,000 after acquiring an additional 714 shares during the period. Versant Capital Management Inc increased its position in shares of Sabra Healthcare REIT by 70.0% in the second quarter. Versant Capital Management Inc now owns 1,465 shares of the real estate investment trust’s stock valued at $29,000 after acquiring an additional 603 shares during the period. Strengthening Families & Communities LLC bought a new position in shares of Sabra Healthcare REIT during the fourth quarter valued at about $29,000. Finally, Danske Bank A S bought a new position in shares of Sabra Healthcare REIT during the third quarter valued at about $30,000. 99.40% of the stock is owned by hedge funds and other institutional investors.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.